Shin Yeu Ong

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Diffuse Large B Cell Lymphoma

Stem Cell Transplantation

Top Venues

American journal of hematology

Leukemia & lymphoma

Blood cancer journal

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Shin Yeu Ong, Jasmine M Zain
Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management. American journal of hematology 99 (3) (2024)
Shin Yeu Ong, Jasmine M Zain
Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management. American journal of hematology (2024)
Shin Yeu Ong, Jasmine M Zain
Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management. American journal of hematology 99 (3) (2024)
Shin Yeu Ong, Jasmine M Zain
Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management. American journal of hematology 99 (3) (2024)
Esther Wei Yin Chang, Valerie Shiwen Yang, Shin Yeu Ong, Hilda Xueqi Kang, Boon Yee Lim, Sanjay de Mel, Esther Ka Yan Ng, Michelle Limei Poon, Ya Hwee Tan, Jianbang Chiang, Eileen Poon, Nagavalli Somasundaram, Mohamad Farid, Tiffany Tang, Miriam Tao, Lay Poh Khoo, Chee Leong Cheng, Dachuan Huang, Choon Kiat Ong, Soon Thye Lim, Jason Yongsheng Chan
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study. Leukemia & lymphoma (2023)
Shin Yeu Ong, Stacy Pak, Matthew G Mei, Yan Wang, Leslie Popplewell, John H Baird, Alex F Herrera, Geoffrey Shouse, Liana Nikolaenko, Jasmine M Zain, James Godfrey, Myo Htut, Ahmed Aribi, Ricardo Spielberger, Joshua Mansour, Stephen J Forman, Joycelynne Palmer, L Elizabeth Elizabeth Budde
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma. American journal of hematology (2023)
Shin Yeu Ong, Melinda Tan Si Yun, Nurul Aidah Abdul Halim, Dheepa Christopher, Wei-Ying Jen, Christian Gallardo, Angeline Tan Hwee Yim, Yeow Kheong Woon, Heng Joo Ng, Melissa Gaik-Ming Ooi, Gee Chuan Wong
Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine. Cancers 14 (15) (2022)
Jasmine Goh, Sanjay De Mel, Michal Marek Hoppe, Masturah Bte Mohd Abdul Rashid, Xi Yun Zhang, Patrick Jaynes, Esther Ka Yan Ng, Nur'Atiqa Diana Binti Rahmat, null Jayalakshmi, Clementine Xin Liu, Limei Poon, Esther Chan, Joanne Lee, Yen Lin Chee, Liang Piu Koh, Lip Kun Tan, Teck Guan Soh, Yi Ching Yuen, Hoi-Yin Loi, Siok Bian Ng, Xueying Goh, Donovan Eu, Stanley Loh, Sheldon Ng, Daryl Tan, Daryl Ming Zhe Cheah, Wan Lu Pang, Dachuan Huang, Shin Yeu Ong, Chandramouli Nagarajan, Jason Yongsheng Chan, Jeslin Chian Hung Ha, Lay Poh Khoo, Nagavalli Somasundaram, Tiffany Tang, Choon-Kiat Ong, Wee-Joo Chng, Soon Thye Lim, Edward Kai-Hua Chow, Anand D Jeyasekharan
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma. Science translational medicine 14 (667) (2022)
Shin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, Yunxin Chen, Yan Chin Tan, Melinda Si Yun Tan, Lawrence Cheng Kiat Ng, Yuh Shan Lee, Colin Phipps, Yeow Tee Goh, Kar Ying Yong, Xin Liu, Wee Joo Chng, Soon Thye Lim, Chandramouli Nagarajan
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma. Blood cancer journal 11 (8) (2021)
Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi, Rehena Sultana, Li Hui Lim, Nicholas Francis Grigoropoulos, Shin Yeu Ong, Mingge Xu, null null, Wee-Joo Chng, Yeow Tee Goh, Chandramouli Nagarajan
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1). Blood cancer journal 11 (9) (2021)
Shin Yeu Ong, Chuen Wen Tan, Vajjhala Ramya, Aisyah A Malik, Xiu Hue Lee, Jordan C C Hwang, Yong Yang, Heng Joo Ng, Lai Heng Lee
Risk factors and predictors of treatment responses and complications in immune thrombocytopenia. Annals of hematology 100 (3) (2021)
Shin Yeu Ong, Colin Phipps, Chandramouli Nagarajan, Tiffany Tang, Soon Thye Lim, Yeow Tee Goh, Yuh Shan Lee
Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia. Leukemia & lymphoma 61 (1) (2019)